SCHEMBL29980508

SCHEMBL29980508

CC1CCCN(C(=O)C(N)=O)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
LMNA P02545 2/20 0.56
POLB P06746 3/20 0.51
MEN1 O00255 1/20 0.51
MAPT P10636 1/20 0.51
KMT2A Q03164 1/20 0.51
RECQL P46063 1/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
HPGD P15428 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GRM5 P41594 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14626911 0.88 ALDH1A1 (0.42) ALDH1A1LMNAPOLBMEN1MAPT
SCHEMBL3588954 0.84 ALDH1A1 (0.59) ALDH1A1LMNAPOLBMEN1MAPT
SCHEMBL3314468 0.84 ALDH1A1 (0.59) ALDH1A1LMNAPOLBMEN1MAPT
SCHEMBL23581936 0.81 ALDH1A1 (0.53) ALDH1A1LMNAPOLBMEN1MAPT
SCHEMBL21138803 0.80 ALDH1A1 (0.65) ALDH1A1LMNAPOLBMEN1MAPT
SCHEMBL27872556 0.79 ALDH1A1 (0.63) ALDH1A1LMNAPOLBMEN1MAPT
SCHEMBL17150933 0.79 ALDH1A1 (0.54) ALDH1A1LMNAPOLBMEN1MAPT
SCHEMBL14311858 0.78 CA12 (0.48) ALDH1A1MAPTKMT2ACA12CA1
SCHEMBL15808643 0.78 CA12 (0.48) ALDH1A1MAPTKMT2ACA12CA1
SCHEMBL15808574 0.78 CA12 (0.48) ALDH1A1MAPTKMT2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492350-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2022-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492350-B2 Compounds and methods of use F12, C1R, ABCG2 ALDH1A1 128/4885LMNA 1976/4885POLB 3098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.